Targeting RNA Coding Mechanisms in Disease Molecular Pathways
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "RNA".
Deadline for manuscript submissions: 20 January 2027 | Viewed by 612
Editor
Special Issue Information
Dear Colleagues,
In recent years, RNA has become a key player in the biology of diseases, evolving beyond its traditional role as a mere messenger to uncover complex and dynamic regulatory functions. Disruptions in RNA coding mechanisms—such as alternative splicing, the function of non-coding RNA (ncRNA) and RNA modifications—are increasingly recognized as significant contributors to the development of various diseases, including cancer, cardiovascular disorders and neurological conditions.
This Special Issue titled "Targeting RNA Coding Mechanisms in Disease Molecular Pathways" explores the latest advances in understanding how RNA dysregulation contributes to these diseases and highlights innovative therapeutic strategies. We invite submissions that detail novel RNA-focused drug discovery approaches, examine the functional roles of ncRNAs and epitranscriptomics in disease pathways and introduce new technologies for manipulating RNA coding mechanisms. By concentrating on this transformative area of research, we aim to provide a comprehensive overview of the field and stimulate the development of next-generation diagnostics and therapies targeting RNA.
Dr. Wangyong Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RNA therapeutics
- RNA modifications (epitranscriptomics)
- non-coding RNA (ncRNA)
- alternative splicing
- RNA-binding proteins (RBPs)
- RNA-targeted small molecules
- gene therapy
- molecular pathways
- disease biomarkers
- RNA vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
